Variant report
Variant | nsv964749 |
---|---|
Chromosome Location | chr5:2050135-2051682 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570617979 | chr5:2050139-2050140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185457842 | chr5:2050174-2050175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546862476 | chr5:2050196-2050197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568040609 | chr5:2050199-2050200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116566999 | chr5:2050244-2050245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10078909 | chr5:2050249-2050250 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs569953659 | chr5:2050277-2050278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13190016 | chr5:2050303-2050304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs558618455 | chr5:2050320-2050321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142263604 | chr5:2050324-2050325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10065111 | chr5:2050328-2050329 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs553186807 | chr5:2050375-2050376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74821409 | chr5:2050422-2050423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4975838 | chr5:2050483-2050484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs146775758 | chr5:2050485-2050486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537880576 | chr5:2050488-2050489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563246168 | chr5:2050505-2050506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76952854 | chr5:2050509-2050510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545854130 | chr5:2050554-2050555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368962330 | chr5:2050579-2050580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200049141 | chr5:2050614-2050615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140516293 | chr5:2050687-2050688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4975837 | chr5:2050736-2050737 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs556641315 | chr5:2050758-2050759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58810703 | chr5:2050765-2050766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561748562 | chr5:2050814-2050815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377153905 | chr5:2050846-2050847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369842397 | chr5:2050847-2050848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35830945 | chr5:2050857-2050858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs58155659 | chr5:2050859-2050860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554305369 | chr5:2050867-2050868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529140112 | chr5:2050907-2050908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189984801 | chr5:2050925-2050926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369643681 | chr5:2050928-2050929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550610754 | chr5:2051001-2051002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181522790 | chr5:2051044-2051045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184597035 | chr5:2051102-2051103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537046566 | chr5:2051123-2051124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9312976 | chr5:2051124-2051125 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs373036383 | chr5:2051141-2051142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570598871 | chr5:2051167-2051168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34380409 | chr5:2051180-2051181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534809627 | chr5:2051209-2051210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13154748 | chr5:2051244-2051245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138365090 | chr5:2051245-2051246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7701070 | chr5:2051254-2051255 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs141350193 | chr5:2051296-2051297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs35208484 | chr5:2051323-2051324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78619394 | chr5:2051380-2051381 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188361349 | chr5:2051385-2051386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 21364760 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:2046000-2056800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr5:2051200-2052000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr5:2051400-2052000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr5:2051600-2052000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |